SCHEMBL10042661

SCHEMBL10042661

c1ccc(-c2ccc3c(c2)c2ccccc2n3-c2cccc(-n3c4ccccc4c4cc(-c5cccc6ccccc56)ccc43)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.45
▸ ATM Q13315 2/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ CA12 O43570 3/20 0.43
▸ CA1 P00915 3/20 0.43
▸ CA2 P00918 3/20 0.43
▸ CA9 Q16790 3/20 0.43
▸ MCL1 Q07820 2/20 0.41
▸ ACMSD Q8TDX5 1/20 0.41
▸ TSPO P30536 1/20 0.38
▸ NTSR1 P30989 2/20 0.38
▸ PDE10A Q9Y233 1/20 0.37
▸ TUBB4A P04350 1/20 0.36
▸ TUBB P07437 1/20 0.36
▸ TUBA3C P0DPH7 1/20 0.36
▸ TUBA1B P68363 1/20 0.36
▸ TUBA4A P68366 1/20 0.36
▸ TUBB4B P68371 1/20 0.36
▸ TUBB3 Q13509 1/20 0.36
▸ TUBB2A Q13885 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25941724 0.97 ATM (0.45) KDM4EATML3MBTL1CA12CA1
SCHEMBL22145947 0.97 ATM (0.45) KDM4EATML3MBTL1CA12CA1
SCHEMBL22145932 0.96 ATM (0.44) KDM4EATML3MBTL1CA12CA1
SCHEMBL21747147 0.95 KDM4E (0.46) KDM4EATML3MBTL1CA12CA1
SCHEMBL21151636 0.95 L3MBTL1 (0.49) KDM4EATML3MBTL1CA12CA1
SCHEMBL10130269 0.95 CA12 (0.46) KDM4EATML3MBTL1CA12CA1
SCHEMBL10130265 0.95 CA12 (0.46) KDM4EATML3MBTL1CA12CA1
SCHEMBL21747012 0.94 KDM4E (0.43) KDM4EATML3MBTL1CA12CA1
SCHEMBL19168560 0.93 L3MBTL1 (0.47) KDM4EATML3MBTL1CA12CA1
SCHEMBL10130142 0.93 L3MBTL1 (0.50) KDM4EATML3MBTL1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8192847-B2 Organic electroluminescent device material, organic electroluminescent device, display and illuminating device KONICA MINOLTA HOLDINGS, INC. (JP) 2012-06-05 — — US disclosed
US-8192847-B2 Organic electroluminescent device material, organic electroluminescent device, display and illuminating device KONICA MINOLTA HOLDINGS, INC. (JP) 2012-06-05 — — US disclosed
US-20090167165-A1 ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2009-07-02 — — US disclosed
US-20090167165-A1 ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090167165-A1 ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE L1CAM, OR10J3, ICOSLG KDM4E 1687/4885ATM 3191/4885L3MBTL1 191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback